Accuray Incorporated, a medical device company, has appointed Eric Pauwels as senior vice president and chief marketing officer.
In his role, Pauwels will report to Euan Thomson, Accuray’s president and CEO, and will oversee the company’s Global Marketing Communications, Product Marketing and Patient Access functions, the company said.
Pauwels has more than 25 years of general management experience in US and European bio-pharmaceutical companies. He has successfully developed and launched more than 20 brands globally from major pharmaceuticals to highly specialized orphan drugs in the therapeutic areas of genetic diseases, cardiovascular disease, urology, gynecology, CNS/neuroscience and infectious diseases.
Pauwels brings more than 15 years of alliance management experience to his new role, having collaborated with commercial partners including GlaxoSmithKline, Genzyme, Dianippon-Sumitomo, Takeda, Abbott, Organon, and Centocor.
Pauwels played a key leadership role in building commercial capabilities in an early stage biotech company at Transkaryotic Therapies (TKT) and leading Shire’s worldwide commercial business for its Human Genetic Disease biotech business unit where he served as SVP, Chief Commercial Officer. Prior to his tenure at Shire, Pauwels held senior management positions with Bayer Healthcare Pharmaceuticals as vice president Global Strategic Marketing, Men’s Health and Cardiovascular Diseases.
“We are extremely excited to have Eric on board at Accuray. His deep global commercial and product launch experience will be an asset to our worldwide marketing efforts,” said Euan S. Thomson, Ph.D., president and CEO of Accuray. “We’ve known that a strong, integrated marketing program is integral to Accuray’s success and believe Eric brings the necessary skills, knowledge and experience to maintain our current leadership, expand awareness and drive further demand for CyberKnife radiosurgery.”